Our CDMO expertise in injectable hyaluronic acid for your medical applications.

SyrHAtech is a Swiss company developing and manufacturing injectable medical devices, mainly based on hyaluronan. We offer CDMO (Contract Development and Manufacturing Organization) activities with a high level of performance, quality and competence.

30 years of expertise in hyaluronic acid

Thanks to the experience of our team acquired over the last 30 years through the genesis of different products such as OVDs, dermal fillers and mesotherapy, and viscosupplements, we are confident that SyrHAtech has all the necessary assets to match your goals. 

Our solutions. We are here for :

  • Syrhatech - Who are we ?

    Develop a product idea

  • Develop a formulation

  • Develop manufacturing technology

    Develop manufacturing technology

  • Our ready-to-use formulations

  • IntexHya technology

    Our IntexHya technology

  • Syrhatec - Formulation

    Our analytical capabilities

  • Our manufacturing capabilities

    Our manufacturing capabilities

  • Syrhatech - technology transfer

    Our technology transfer capabilities

Do you have a project to share with us?
Syrhatec - Formulation


Are you a student, a doctoral student, a young researcher or a startup, and  you are searching for a manufacturer moving to the industrialization stage? 

SyrHA offers the manufacturing of one batch in its facility to let you carrying out your first physico-chemical and bio compatibility tests. 

We accompany you throughout your project

  • Marketing

  • Research

  • Development

  • Safety test

  • Formula

  • Performance test

  • Regulation

  • Manufacturing

  • Analysis


Explore our environment

  • Company

     Join us at IMCAS Paris! 

    We’re delighted to announce that our team will be taking part in the IMCAS 2024…

    IMCAS 2024 World Congress in Paris
  • Company

    SyrHATech is thrilled to install its new autoclave!

    In the field of sterile medical device manufacturing, the terminal sterilization of your products is…

    SyrHATech new autoclave
  • Company

    SyrHATech goes to CPHI Barcelona – from 10/24 to 10/26

    The CPHI (Convention on Pharmaceutical Ingredients) is the reference event for the pharmaceutical industry. Itinerant…

    CPHI Barcelona 2023
  • Company

    Inauguration of Syrhatech’s new premises in Geneva

    The Syrhatech team was delighted to share a convivial moment on its terrace on the…

    Inauguration of Syrhatech's new premises in Geneva
  • Company

    Development of a specific syringe for wrinkle filler

    Our customer contacts us to validate the design of a syringe made of plastic by…

  • Company

    Development of an innovative gel with very high concentration

    Our client contacts us to industrialize a new manufacturing technique, compatible with the objectives of…

  • Company

    Technology transfer

    Our team relies on its many years of experience and past successes, to prepare and…

    Syrhatech - technology transfer
  • Company

    Development of a cross-linked HA formulation containing peptides

    At the request of our customer, this cross-linked HA product incorporates peptides for various therapeutic…

    Syrhatech - Value added technology
  • Company

    Development of a cross-linked hydrogel similar to an existing product

    Reverse engineering and formulation of cross-linked HA for specific (non-aesthetic) applications, and development of steam…

  • Company

    Formulation of a new polymer

    Technology transfer and development of a manufacturing process for a polysaccharide other than hyaluronic acid…

    Syrhatech - Who are we ?